About BioCina
BioCina is a company based in Thebarton (Australia) founded in 2018 by Ian Wisenberg. BioCina offers products and services including Microbial Manufacturing, pDNA Manufacturing, mRNA Manufacturing, Technology Transfer, and Analytical Development. BioCina operates in a competitive market with competitors including Wacker Chemie, AMILI, Enduro, Eleszto Genetika and Shenzhen Qianhai Xiaozao Technology, among others.
- Headquarter Thebarton, Australia
- Founders Ian Wisenberg
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$3.3 M (USD), Grant
Apr 26, 2023
-
Investors
NHMRC
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioCina
BioCina offers a comprehensive portfolio of products and services, including Microbial Manufacturing, pDNA Manufacturing, mRNA Manufacturing, Technology Transfer, and Analytical Development.
Service for bacterial protein expression and vaccine manufacturing.
Process for plasmid DNA adjuvants used in vaccines and therapies.
Production of messenger RNA for clinical and commercial applications.
Service to scale and optimize product processes for manufacturing.
Development of methods for testing and validating biologics programs.
People of BioCina
Unlock access to complete
Funding Insights of BioCina
Investors in BioCina
BioCina has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NHMRC and Department of Industry, Science and Resources.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funds medical research, advises government, and facilitates health professional networking in Australia.
|
Locked | Locked | Locked | |
|
Government department focused on industry, science, and resource development in Australia.
|
Locked | Locked | Locked |
Investor details for BioCina
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioCina
Investment portfolio details for BioCina
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioCina
Detailed financials for BioCina
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocina Comparisons
Peer comparison for BioCina
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioCina
BioCina operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wacker Chemie, AMILI, Enduro, Eleszto Genetika and Shenzhen Qianhai Xiaozao Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Silicones, polymers, and bio-solutions are manufactured for various industries.
|
|
| Locked | Locked | Locked |
Gut microbiome insights, analytics, tests, and therapeutics are provided.
|
|
| Locked | Locked | Locked |
Microbial strains are manufactured by Enduro as a CDMO.
|
|
| Locked | Locked | Locked |
CDMO offers microbial expression systems-based biologics development
|
|
| Locked | Locked | Locked |
Offers microbial expression systems-based biologics development and manufacturing services
|
Detailed competitors of BioCina
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocina
Complete news archive for BioCina
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioCina
BioCina was founded in 2018 and raised its 1st funding round 4 years after it was founded.
BioCina is headquartered in Thebarton, Australia. It is registered at Thebarton, South Australia, Australia.
Ian Wisenberg is the current CEO of BioCina. They have also founded this company.
BioCina was established in 2018 in Thebarton, Australia, as a contract development and manufacturing organization in the biotechnology sector. Microbial expression systems are employed for biologics development and production services. Operations focus on supporting clients through scalable manufacturing processes tailored to microbial platforms. The company serves global partners in the biopharmaceutical industry from its Australian base.
BioCina's top competitors include Wacker Chemie, AMILI and Enduro.
BioCina offers Microbial Manufacturing, pDNA Manufacturing, mRNA Manufacturing, Technology Transfer, and Analytical Development.
BioCina has 2 investors. Key investors include NHMRC, and Department of Industry, Science and Resources.